Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs

被引：0
|
作者：
T Iwasa
I Okamoto
K Takezawa
K Yamanaka
T Nakahara
A Kita
H Koutoku
M Sasamata
E Hatashita
Y Yamada
K Kuwata
M Fukuoka
K Nakagawa
机构：
[1] Kinki University School of Medicine,Department of Medical Oncology
[2] 377-2 Ohno-higashi,Department of Medical Oncology
[3] Osaka-Sayama,undefined
[4] Osaka 589-8511,undefined
[5] Japan,undefined
[6] Institute of Drug Discovery Research,undefined
[7] Astellas Pharma Inc.,undefined
[8] 21 Miyukigaoka,undefined
[9] Tsukuba-shi,undefined
[10] Ibaraki 305-8585,undefined
[11] Japan,undefined
[12] Kinki University School of Medicine,undefined
[13] Sakai Hospital,undefined
[14] 2-7-1 Harayamadai,undefined
[15] Minami-ku Sakai,undefined
[16] Osaka 590-0132,undefined
[17] Japan,undefined
来源：
British Journal of Cancer | 2010年 / 103卷
关键词：
survivin; YM155; apoptosis; DNA repair; non-small cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：36 / 42
页数：6
相关论文
共 50 条
  • [21] Antitumor effect of YM155, a novel small-molecule survivin suppressant, via mitochondrial apoptosis in human MFH/UPS
    Minoda, Masaya
    Kawamoto, Teruya
    Ueha, Takeshi
    Kamata, Etsuko
    Morishita, Masayuki
    Harada, Risa
    Toda, Mitsunori
    Onishi, Yasuo
    Hara, Hitomi
    Kurosaka, Masahiro
    Akisue, Toshihiro
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (03) : 891 - 899
  • [22] Tumor regression induced by YM155, a novel, survivin suppressant, in human diffuse large B-cell lymphoma models
    Kaneko, Naoki
    Kita, Aya
    Nakahara, Takahito
    Nakata, Mari
    Koutoku, Hiroshi
    Sasamata, Masao
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 260P - 260P
  • [23] Tumor regression induced by YM155, a novel, small molecule survivin suppressant, in experimental human lung tumor models.
    Nakahara, Takahito
    Takeuchi, Masahiro
    Kinoyama, Isao
    Kita, Aya
    Yamanaka, Kentaro
    Matsuhisa, Akira
    Sasamata, Masao
    CANCER RESEARCH, 2006, 66 (08)
  • [24] Schedule-dependent antitumor activity of YM155, a novel small molecule survivin suppressant, in experimental human hormone refractory prostate carcinoma xenograft
    Nakahara, T
    Takeuchi, M
    Kinoyama, I
    Minematsu, T
    Matsuhisa, A
    Kita, A
    Tominaga, F
    Yamanaka, K
    Sasamata, M
    ANNALS OF ONCOLOGY, 2006, 17 : 38 - 38
  • [25] Combination of YM155, a Survivin Suppressant, with Bendamustine and Rituximab: A New Combination Therapy to Treat Relapsed/Refractory Diffuse Large B-cell Lymphoma
    Kaneko, Naoki
    Mitsuoka, Keisuke
    Amino, Nobuaki
    Yamanaka, Kentaro
    Kita, Aya
    Mori, Masamichi
    Miyoshi, Sosuke
    Kuromitsu, Sadao
    CLINICAL CANCER RESEARCH, 2014, 20 (07) : 1814 - 1822
  • [26] Pharmacokinetics, distribution and excretion of YM155 monobromide, a novel small-molecule survivin suppressant, in male and pregnant or lactating female rats
    Minematsu, Tsuyoshi
    Sonoda, Takuya
    Hashimoto, Tadashi
    Iwai, Megumi
    Oppeneer, Todd
    Felder, Laurie
    Shirai, Nobuaki
    Miyashita, Aiji
    Usui, Takashi
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2012, 33 (03) : 160 - 169
  • [27] YM155, a novel small molecule survivin suppressant, exhibits curative antitumor activities in experimental human malignant lymphoma models in vivo
    Kita, A.
    Nakahara, T.
    Yamanaka, K.
    Koutoku, H.
    Takeuchi, M.
    Kinoyama, I.
    Matsuhisa, A.
    Sasamata, M.
    EJC SUPPLEMENTS, 2006, 4 (12): : 116 - 116
  • [28] Combination of YM155, a survivin suppressant with a STAT3 inhibitor: A new strategy to treat diffuse large B-cell lymphoma
    Kaneko, Naoki
    Kita, Aya
    Yamanaka, Kentaro
    Mori, Masamichi
    LEUKEMIA RESEARCH, 2013, 37 (09) : 1156 - 1161
  • [29] Formulation Design and Evaluation of Liposomal Sepantronium Bromide (YM155), a Small-Molecule Survivin Suppressant, Based on Pharmacokinetic Modeling and Simulation
    Kohsuke Shakushiro
    Hiroki Kawano
    Mari Nakata
    Aya Kita
    Atsushi Maeda
    Shunsuke Watanabe
    Kazuhiro Sako
    Naoto Oku
    Pharmaceutical Research, 2015, 32 : 238 - 247
  • [30] Radiosynthesis, biodistribution and imaging of [11C]YM155, a novel survivin suppressant, in a human prostate tumor-xenograft mouse model
    Murakami, Yoshihiro
    Matsuya, Takahiro
    Kita, Aya
    Yamanaka, Kentaro
    Noda, Akihiro
    Mitsuoka, Keisuke
    Nakahara, Takahito
    Miyoshi, Sosuke
    Nishimura, Shintaro
    NUCLEAR MEDICINE AND BIOLOGY, 2013, 40 (02) : 221 - 226
12345